Ocular involvement following Bacillus Calmette-Guerin immunotherapy for bladder carcinoma

Clin Exp Ophthalmol. 2014 Jul;42(5):494-5. doi: 10.1111/ceo.12252. Epub 2013 Dec 27.

Authors

Sudha Cugati¹, Jagjit Singh Gilhotra, Stewart Lake, David L Gordon

Affiliation

¹ Department of Ophthalmology, Flinders Medical Centre, Bedford Park, South Australia, Australia; Department of Ophthalmology, The University of Adelaide, Adelaide, South Australia, Australia.

PMID: 24372891
DOI: 10.1111/ceo.12252

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adjuvants, Immunologic / adverse effects*
Adjuvants, Immunologic / therapeutic use
Administration, Intravesical
Aged
Antitubercular Agents / therapeutic use
BCG Vaccine / adverse effects*
BCG Vaccine / therapeutic use
Carcinoma, Transitional Cell / drug therapy*
Combined Modality Therapy
Female
Fluorescein Angiography
Glucocorticoids / therapeutic use
Humans
Immune Reconstitution Inflammatory Syndrome / diagnosis
Immune Reconstitution Inflammatory Syndrome / drug therapy
Immune Reconstitution Inflammatory Syndrome / etiology*
Immunotherapy
Male
Tuberculosis, Ocular / diagnosis
Tuberculosis, Ocular / drug therapy
Tuberculosis, Ocular / etiology*
Urinary Bladder Neoplasms / drug therapy*
Uveitis / diagnosis
Uveitis / drug therapy
Uveitis / etiology*

Substances

Adjuvants, Immunologic
Antitubercular Agents
BCG Vaccine
Glucocorticoids